Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Comparing Renal Effects of Vancomycin Combined With Either Piperacillin/Tazobactam or Meropenem: VPT Patient Safety (VPS) Study

NCT07556107 is registered in ClinicalTrials.gov with Bassett Healthcare as lead sponsor.

NCT NCT07556107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07556107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Comparing Renal Effects of Vancomycin Combined With Either Piperacillin/Tazobactam or Meropenem: VPT Patient Safety (VPS) Study
Lead sponsor
Bassett Healthcare
Phase
Phase 4
Overall status
Recruiting
Start date
August 17, 2026
Completion date
December 31, 2028
Enrollment
852 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, infection, sepsis